{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:54:31Z","timestamp":1767848071813,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.revmed.2016.10.392","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T09:47:49Z","timestamp":1479721669000},"page":"393-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Les atteintes neurologiques au cours de la sarco\u00efdose\u00a0: diagnostic et traitement"],"prefix":"10.1016","volume":"38","author":[{"given":"F.","family":"Cohen Aubart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Galanaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Haroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Psimaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mathian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Le-Thi Huong Boutin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Charlotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Maillart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.10.392_bib0365","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2016.10.392_bib0370","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2016.10.392_bib0375","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2016.10.392_bib0380","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.57.5.927","article-title":"Long-term follow-up of neurosarcoidosis","volume":"57","author":"Ferriby","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0385","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1474-4422(04)00805-1","article-title":"Neurosarcoidosis: a clinical dilemma","volume":"3","author":"Hoitsma","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0390","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jnnp.2008.151977","article-title":"Neurosarcoidosis: a study of 30\u00a0new cases","volume":"80","author":"Joseph","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2016.10.392_bib0395","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","article-title":"Diagnosis and management of neurological sarcoidosis","volume":"157","author":"Lower","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2016.10.392_bib0400","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1212\/WNL.37.3.461","article-title":"Neurosarcoidosis: the long-term clinical course","volume":"37","author":"Luke","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0405","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcp042","article-title":"Presentations and outcomes of neurosarcoidosis: a study of 54\u00a0cases","volume":"102","author":"Pawate","year":"2009","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2016.10.392_bib0410","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mus.20683","article-title":"Granulomatous myositis: a clinical study of thirteen cases","volume":"35","author":"Le Roux","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2016.10.392_bib0415","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2006.01.014","article-title":"The natural history and long-term outcome of 57\u00a0limb sarcoidosis neuropathy cases","volume":"244","author":"Burns","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2016.10.392_bib0420","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.semarthrit.2004.07.011","article-title":"Clinical and magnetic resonance imaging manifestations of neurosarcoidosis","volume":"34","author":"Spencer","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.10.392_bib0425","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archneur.64.5.691","article-title":"Aggressive therapy for neurosarcoidosis: long-term follow-up of 48\u00a0treated patients","volume":"64","author":"Scott","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0430","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00005792-199009000-00001","article-title":"Neurosarcoidosis: signs, course and treatment in 35\u00a0confirmed cases","volume":"69","author":"Chapelon","year":"1990","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2016.10.392_bib0435","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archneur.1995.00540330053014","article-title":"Therapeutic considerations in patients with refractory neurosarcoidosis","volume":"52","author":"Agbogu","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0440","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.37.5.878","article-title":"Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations","volume":"37","author":"Stern","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0445","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1378\/chest.112.1.220","article-title":"Neurosarcoidosis: a personal perspective based on the study of 37\u00a0patients","volume":"112","author":"Sharma","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.10.392_bib0450","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","article-title":"Central nervous system sarcoidosis\u00a0\u2013\u00a0diagnosis and management","volume":"92","author":"Zajicek","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2016.10.392_bib0455","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1148\/radiology.214.2.r00fe05411","article-title":"Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy","volume":"214","author":"Dumas","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0460","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/MD.0b013e31815585aa","article-title":"Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9\u00a0patients and review of the literature","volume":"86","author":"Bihan","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2016.10.392_bib0465","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAO.0000000000000501","article-title":"Cranial base manifestations of neurosarcoidosis: a review of 305\u00a0patients","volume":"36","author":"Carlson","year":"2015","journal-title":"Otol Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0470","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/NRL.0b013e3182704d04","article-title":"Isolated neurosarcoidosis: case series in 2\u00a0sarcoidosis centers","volume":"18","author":"Nozaki","year":"2012","journal-title":"Neurologist"},{"key":"10.1016\/j.revmed.2016.10.392_bib0475","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.ejim.2011.08.019","article-title":"Neurosarcoidosis: report of 30\u00a0cases and a literature survey","volume":"22","author":"Gascon-Bayarri","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2016.10.392_bib0480","doi-asserted-by":"crossref","first-page":"e3277","DOI":"10.1097\/MD.0000000000003277","article-title":"Neurosarcoidosis in a tertiary referral center: a cross-sectional cohort study","volume":"95","author":"Leonhard","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2016.10.392_bib0485","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11940-013-0242-9","article-title":"Neurosarcoidosis","volume":"15","author":"Nozaki","year":"2013","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0490","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1016\/j.lpm.2011.12.017","article-title":"Neurosarcoidosis: clinical manifestations, diagnosis and treatment","volume":"41","author":"Nozaki","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2016.10.392_bib0495","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MD.0b013e3181d5c6b4","article-title":"Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31\u00a0patients in a case-control study","volume":"89","author":"Cohen Aubart","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2016.10.392_bib0500","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00415-016-8092-5","article-title":"Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20\u00a0BIOPSY-PROVEN patients","volume":"263","author":"Durel","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MAJ.0b013e3182808781","article-title":"Spinal cord neurosarcoidosis","volume":"347","author":"Sohn","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.revmed.2016.10.392_bib0510","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00415-011-6080-3","article-title":"Clinical features of spinal cord sarcoidosis: analysis of 17\u00a0neurosarcoidosis patients","volume":"258","author":"Sakushima","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0515","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.surneu.2007.01.068","article-title":"Obstructive hydrocephalus and progressive psychosis: rare presentations of neurosarcoidosis","volume":"69","author":"Westhout","year":"2008","journal-title":"Surg Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0520","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","article-title":"Hypothalamo-pituitary sarcoidosis: a multicenter study of 24\u00a0patients","volume":"105","author":"Langrand","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2016.10.392_bib0525","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jns.2014.09.033","article-title":"Sarcoid neuropathy: correlation of nerve ultrasound, electrophysiological and clinical findings","volume":"347","author":"Kerasnoudis","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2016.10.392_bib0530","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jneuroim.2010.03.012","article-title":"Neurosarcoidosis presenting as an anterior horn syndrome","volume":"225","author":"Souayah","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0535","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.0b013e3181bacf05","article-title":"Intraepidermal nerve fiber density and its application in sarcoidosis","volume":"73","author":"Bakkers","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0540","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-015-7680-0","article-title":"Clinicopathological features of sarcoidosis manifesting as generalized chronic myopathy","volume":"262","author":"Maeshima","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0545","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/heartjnl-2015-308708","article-title":"Consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"102","author":"Birnie","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.revmed.2016.10.392_bib0550","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2013.09.008","article-title":"Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity","volume":"335","author":"Wengert","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2016.10.392_bib0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.05.020","article-title":"Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis","volume":"285","author":"Bridel","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0560","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2169\/internalmedicine.54.3283","article-title":"Interleukin 10\u00a0level in the cerebrospinal fluid as a possible biomarker for lymphomatosis cerebri","volume":"54","author":"Hashiguchi","year":"2015","journal-title":"Intern Med"},{"key":"10.1016\/j.revmed.2016.10.392_bib0565","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaneurol.2014.395","article-title":"Immunophenotyping of cerebrospinal fluid cells in multiple sclerosis: in search of biomarkers","volume":"71","author":"Alvermann","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0570","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0575","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1468-1331.2012.03783.x","article-title":"Neurosarcoidosis-related intracranial haemorrhage: three new cases and a systematic review of the literature","volume":"20","author":"O\u2019Dwyer","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0580","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.02.036","article-title":"Isolated central nervous system vasculitis as a manifestation of neurosarcoidosis","volume":"25","author":"Macedo","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.revmed.2016.10.392_bib0585","article-title":"Spinal Koebner phenomenon: medullar sarcoidosis facing a discal hernia","author":"Isabel","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2016.10.392_bib0590","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0595","first-page":"736","article-title":"Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee","volume":"160","author":"Statement on sarcoidosis","year":"1999","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.revmed.2016.10.392_bib0600","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.revmed.2016.05.021","article-title":"\u00c9cho-endoscopie bronchique (EBUS) pour l\u2019interniste","volume":"37","author":"Stern","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.10.392_bib0605","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clineuro.2012.03.042","article-title":"FDG PET findings leading to diagnosis of neurosarcoidosis","volume":"115","author":"Bartels","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.revmed.2016.10.392_bib0610","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.revmed.2015.06.003","article-title":"Manifestations neurologiques anormales chez un homme de 44\u00a0ans","volume":"37","author":"Patient","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2016.10.392_bib0615","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2016.10.392_bib0620","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1097\/RLU.0b013e318279f264","article-title":"Functional imaging in extrapulmonary sarcoidosis: FDG-PET\/CT and MR features","volume":"39","author":"Soussan","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.revmed.2016.10.392_bib0625","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jns.2009.08.060","article-title":"Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis","volume":"287","author":"Bolat","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2016.10.392_bib0630","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.10.392_bib0635","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1212\/WNL.0b013e318212aafb","article-title":"Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy","volume":"76","author":"Androdias","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0640","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.10.392_bib0645","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2016.10.392_bib0650","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archneur.55.9.1248","article-title":"Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement","volume":"55","author":"Sharma","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0655","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archneur.1992.00530340089023","article-title":"The treatment of neurosarcoidosis with cyclosporine","volume":"49","author":"Stern","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0660","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clineuro.2015.05.032","article-title":"The use of cladribine in neurosarcoidosis: a report of two cases","volume":"136","author":"Bhagwan","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.revmed.2016.10.392_bib0665","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1212\/WNL.0b013e3181ec7ff9","article-title":"A case of neurosarcoidosis successfully treated with rituximab","volume":"75","author":"Bomprezzi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0670","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.00227014","article-title":"Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis","volume":"46","author":"Vorselaars","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.10.392_bib0675","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/01.wnl.0000341278.26993.22","article-title":"Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil","volume":"72","author":"Moravan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0680","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/WNF.0000000000000047","article-title":"Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice","volume":"37","author":"Lorentzen","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.revmed.2016.10.392_bib0685","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.10.392_bib0690","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jnnp.2008.149989","article-title":"Treatment of refractory neurosarcoidosis with Infliximab","volume":"81","author":"Santos","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2016.10.392_bib0695","first-page":"91","article-title":"Practical eminence and experience-based recommendations for use of TNF-alpha inhibitors in sarcoidosis","volume":"31","author":"Drent","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2016.10.392_bib0700","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1183\/09031936.00055213","article-title":"Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis","volume":"43","author":"Vorselaars","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2016.10.392_bib0705","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1212\/WNL.0000000000000318","article-title":"Progressive multifocal leukoencephalopathy in patients with sarcoidosis","volume":"82","author":"Jamilloux","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2016.10.392_bib0710","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/qjmed\/hct052","article-title":"Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18\u00a0cases","volume":"106","author":"Bernard","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.revmed.2016.10.392_bib0715","first-page":"182","article-title":"Sarcoidosis and risk of venous thromboembolism: a systematic review and meta-analysis","volume":"32","author":"Ungprasert","year":"2015","journal-title":"Sarcoidosis Vasc Diff Lung Dis"},{"key":"10.1016\/j.revmed.2016.10.392_bib0360","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0761-8425(04)71582-X","article-title":"Infections opportunistes et sarco\u00efdose","volume":"21","author":"Girard","year":"2004","journal-title":"Rev Mal Respir"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316309730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316309730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:37:17Z","timestamp":1759336637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866316309730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0248866316309730"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.10.392","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les atteintes neurologiques au cours de la sarco\u00efdose\u00a0: diagnostic et traitement","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.10.392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}